PET & MRI based Alzheimer’s Disease associated
protein quantitative analysis software
PET brain scans for Alzheimer's Disease by accumulation of Beta-amyloid
which have been used until now utilizes analysis based on visual standards,
and therefore, had to be reliant on the diagnostic accuracy of evaluators with high level of expertise.
- FDA, CE Marking, MFDS approved
- Commercially available
Quantitative analysis of Beta-amyloid protein by SUVR
(Standardized Uptake Value Ratio)
It can be used in an objective solution on the clinical study fields, enabling quantitative analysis of amyloid PET imaging
and thus delivering data on the brain location through the integration with MRI images.
SUVR is the most common quantitative method used to make regional comparisons within a subject as well as between subjects and computed as the degree of radiotracer uptake in a target region of interest with respect to a reference region.
'Heuron-Alzheimer' supports automatic quantification of the Beta-amyloid protein in Alzheimer's Disease.
Calculating SUVR automatically for analyzing deposit level of Beta-amyloid
and thus delivering data on the brain location through the integration with MRI images.
SUVR is the most common quantitative method used to make regional comparisons within a subject as well as between subjects and computed as the degree of radiotracer uptake in a target region of interest with respect to a reference region.
'Heuron-Alzheimer' supports automatic quantification of the Beta-amyloid protein in Alzheimer's Disease.
Calculating SUVR automatically for analyzing deposit level of Beta-amyloid
Comparison of average required
time for SUVR calculation
(*Time may vary subject to read-in area)
Veuron-Brain-pAb
patient info
| ID 30641163 | Sex Male |
| Name ANONYMITY | Age 68Y |
Results
| Global | 0.76 |
| Frontal Lobe | 0.81 |
| Parietal Lobe | 0.78 |
| Temporal Lobe | 0.66 |
| Occipital Lobe | 0.55 |
| Post. Cingulate | 0.77 |
(*Result may vary depending upon type of isotope)
Beta-Amyloid as a biomarker for Alzheimer's Disease
Alzheimer's Disease(AD) pathogenesis is widely believed to be driven by the production and deposition of the Beta-amyloid peptide.
Beta-amyloid is the first protein that begins to accumulate when Alzheimer's Disease(AD) is contracted, and it is used as an
important biomarker in diagnosing AD.
'Heuron-Alzheimer' analyzes amyloid PET images and presents quantitative results to support diagnose and clinical trials.
Beta-amyloid is the first protein that begins to accumulate when Alzheimer's Disease(AD) is contracted, and it is used as an
important biomarker in diagnosing AD.
'Heuron-Alzheimer' analyzes amyloid PET images and presents quantitative results to support diagnose and clinical trials.
